Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy
Clinical trial NCT01828762 · COMPLETED
Trial details
- NCT number
- NCT01828762
- Sponsor
- Shanghai AbelZeta Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-12-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.